IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 334 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $657,260 | +85.1% | 16,019 | +79.7% | 0.10% | +56.5% |
| Q2 2021 | $355,000 | -85.3% | 8,912 | -79.2% | 0.06% | -80.3% |
| Q4 2020 | $2,417,000 | +695.1% | 42,747 | +568.1% | 0.32% | +707.7% |
| Q3 2020 | $304,000 | -77.3% | 6,398 | -71.9% | 0.04% | -77.3% |
| Q2 2020 | $1,342,000 | -19.5% | 22,765 | -35.4% | 0.17% | -22.2% |
| Q1 2020 | $1,667,000 | +149.6% | 35,254 | +218.9% | 0.22% | +99.1% |
| Q4 2019 | $668,000 | – | 11,055 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
| Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
| Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
| BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
| Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
| Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
| Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
| Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
| SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
| TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |